Resultados de la búsqueda 621-630 of 11380 for weakened immune system
Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...
A Study Of CA-4948 In Patients With Relapsed Or Refractory Primary Central Nervous System Lymphoma ... Low-Risk And Low Risk Fusion Negative Rhabdomyosarcoma.
The purpose of this study is to analyze how the immune ... A Study Of CA-4948 In Patients With Relapsed Or Refractory Primary Central Nervous System Lymphoma.
The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer. T cells fight infections and, in some cases, can also ...
The purpose of this study is to analyze the effectiveness and safety of an embolic protection device compared to a standard aortic cannula to reduce the ...
Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...
Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of this study is to combine MRI images with histologic and genetic analysis of cancer (from blood and ...
Exactly why hamartomatous polyps form is not known. But researchers think it may be that the STK11 gene change affects how cells grow and divide, which can ...
The purpose of this study is to evaluate a low ... Impact Of Surgical Removal Or Reduction Procedures On Markers Of Immune ... Key secondary endpoints are toxicity, ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?